Research Status of Neuroprotective therapy for Cerebral Ischemia / 国际脑血管病杂志
International Journal of Cerebrovascular Diseases
; (12): 523-527, 2008.
Article
en Zh
| WPRIM
| ID: wpr-399457
Biblioteca responsable:
WPRO
ABSTRACT
Although thrombolytic therapy is the only method recommended by the Food and Drug Administration(FDA)for acute ischemic stroke,the time window limits its application.Thus,neuroprotective research,which has a wider application become the focus.This article summarizes the neruoprotective methods in animal researches and clinical trials.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
International Journal of Cerebrovascular Diseases
Año:
2008
Tipo del documento:
Article